Previous close | 40.34 |
Open | 40.34 |
Bid | 38.90 |
Ask | 41.80 |
Strike | 330.00 |
Expiry date | 2025-01-17 |
Day's range | 40.34 - 40.34 |
Contract range | N/A |
Volume | |
Open interest | 10 |
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.
While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.